Skip to Content

W975 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint W975 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Wockhardt USA.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W975

Divalproex Sodium Delayed-Release

Imprint
W975
Strength
500 mg
Color
White
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wockhardt USA
National Drug Code (NDC)
64679-0975
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, dimethicone, hypromelloses, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, polysorbate 80, povidone, silicon dioxide, sodium bicarbonate, sodium lauryl sulfate, corn starch, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.